A randomized, double-blind, placebo-controlled trial of urate-elevating inosine treatment to slow clinical decline in early Parkinson disease (“Inosine Phase 3”)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/15 → 12/31/19

Funding

  • Massachusetts General Hospital (Agmt 4/24/17 // 5U01NS090259-03)
  • National Institute of Neurological Disorders and Stroke (Agmt 4/24/17 // 5U01NS090259-03)